Globus Medical (NYSE:GMED) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:15 PM.
Here's what investors need to know about the announcement.
Earnings
Globus Medical missed estimated earnings by 10.64%, reporting an EPS of $0.42 versus an estimate of $0.47.
Revenue was up $3.21 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 0.14% drop in the share price the next day.
Here's a look at Globus Medical's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.47 | 0.45 | 0.44 | 0.37 |
| EPS Actual | 0.49 | 0.50 | 0.56 | 0.49 |
| Revenue Estimate | 243.52M | 228.35M | 224.64M | 198.39M |
| Revenue Actual | 250.02M | 229.72M | 251.02M | 227.34M |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Guidance
Globus Medical management provided guidance for FY 2022, expecting earnings between $2.1 and $2.1 per share.
To track all earnings releases for Globus Medical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
